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Background and Purpose: In small arteries, SKCa and IKCa channels restricted to the 
vascular endothelium generate hyperpolarization that underpins the NO- and PGI2-
independent, EDHF response that is the predominate endothelial mechanism for 
vasodilatation. As neuronal IKCa channels can be negatively regulated by PKA, we 
investigated whether β-adrenoceptor stimulation, which signals through cAMP/PKA, 
might influence endothelial cell hyperpolarization and as a result modify the 
associated vasodilatation.  
Experimental Approach: Rat isolated small mesenteric arteries were pressurized to 
measure vasodilatation and endothelial cell [Ca2+]i, mounted in a wire myograph to 
measure smooth muscle membrane potential or dispersed into endothelial cell sheets 
for membrane potential recording.  
Key results: Intraluminal perfusion of β-adrenoceptor agonists inhibited 
endothelium-dependent dilatation to ACh (1 nM – 10 µM) without modifying the 
associated changes in endothelial cell [Ca2+]i. The inhibitory effect of β-adrenoceptor 
agonists was mimicked by direct activation of adenylyl cyclase with forskolin, 
blocked by the β-adrenoceptor antagonists propranolol (non-selective), atenolol (β1) 
or the PKA inhibitor KT-5720; but remained unaffected by ICI 118,551 (β2) or 
glibenclamide (KATP channel blocker). Endothelium-dependent hyperpolarization to 
ACh was also inhibited by β-adrenoceptor stimulation in both intact arteries and in  
endothelial cells sheets. Blocking IKCa (with 1 µM TRAM-34) but not SKCa (50 nM 
apamin) channels prevented β-adrenoceptor agonists from suppressing either 
hyperpolarization or vasodilatation to ACh. 
Conclusions and Implications: In resistance arteries, endothelial cell β1-
adrenoceptors link to inhibit endothelium-dependent hyperpolarization and the A
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resulting vasodilatation to ACh. This effect appears to reflect inhibition of endothelial 
IKCa-channels and may be one consequence of raised circulating catecholamines. 
 
 
Keywords: acetylcholine; adrenergic (ant)agonists; β-adrenoceptor; endothelial 
receptors; protein kinase A. 
 
Abbreviations: ACh, acetylcholine; Ca2+, free calcium ions; [Ca2+]i, intracellular 
concentration of Ca2+; EDH, endothelium-derived hyperpolarization; (e)NOS, 
(endothelial) nitric oxide synthase; MOPS, 3-[N-morpholino]propane-sulfonic acid; 
L-NAME, Nω-nitro-L-arginine methyl ester hydrochloride; NA, noradrenaline; PE, 
phenylephrine; SKCa, small conductance Ca2+-activated K+ channels; IKCa, 
intermediate conductance Ca2+-activated K+ channels; KATP, ATP-sensitive K+  
channels; VGCC, voltage-gated Ca2+ channels. 
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Introduction 
Vascular endothelial cells contain two forms of KCa channel, the small and 
intermediate conductance Ca2+-activated potassium channels (SKCa and IKCa, 
respectively; (Edwards et al., 1998). The SKCa and IKCa channels can be regulated 
independently to generate endothelial cell hyperpolarization (Crane et al., 2003), 
reflecting a differential distribution of the two subtypes within the cell membrane 
(Dora et al., 2008). Activated by increases in endothelial cell [Ca2+], they generate 
hyperpolarization that spreads to relax the adjacent smooth muscle. Historically this 
effect was defined as the EDHF response, because it was thought solely to reflect the 
action of a diffusible hyperpolarizing factor. It is now clear that hyperpolarization 
spreads to the muscle partly through myo-endothelial gap junctions (MEGJs) and 
partly via a diffusible factor that in the mesenteric artery is K+ effluxing through the 
KCa channels.  As such the term, EDH is now used to describe this complex NO/PGI2-
independent signalling pathway, that is a predominate endothelial influence on 
function in small arteries where the smooth muscle cells express voltage-dependent 
Ca2+-channels in high density (reviewed by Garland et al., 2011a). 
 
We have previously shown that the activation of adenylyl cyclase (with forskolin) can 
selectively suppress the IKCa (not SKCa) channel component of EDH during 
endothelial cell stimulation with ACh in mesenteric resistance arteries (Dora et al., 
2008). This observation is consistent with data from neurons (Neylon et al., 2006; 
Vogalis et al., 2003) and Xenopus oocytes (Neylon et al., 2004), where IKCa channels 
are suppressed by activation of protein kinase A (PKA). Physiologically, vascular β-
adrenoceptors couple through Gs to generate cAMP, raising the possibility that A
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endogenous catecholamines might act in part to modulate endothelial cell IKCa 
hyperpolarization and thus influence vasodilatation.   
 
β-adrenoceptors have been visualized directly on endothelial cells in the rat 
mesenteric artery, but it is not clear what functional role, if any, these receptors serve 
(Briones et al., 2005). They do not appear to exert any significant functional influence 
through NO, as dilatation to β-adrenoceptor agonists was not altered by blocking NO 
synthase activity (Briones et al., 2005; Garland et al., 2011b). We therefore 
investigated the possibility that the β-adrenoceptors might modulate endothelium-
dependent responses to ACh in resistance arteries by targeting IKCa channels and 
influencing hyperpolarization. Our data indicate that adrenergic agonists can impair 
local endothelium-dependent dilatation by suppressing the EDH generated by IKCa 
channels through a cAMP-dependent mechanism. Furthermore, they show this action 
is mediated, at least in part, by β1-adrenoceptors located on the endothelium. 
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Methods  
 
Preparation of arteries for pressure or wire myography 
Animal use complied with the University of Oxford local ethical guidelines and the 
Animals (Scientific Procedures) Act 1986. Male Wistar rats (225-250g) were killed 
by cervical dislocation and exsanguination, as specified by Schedule 1 of the Animals 
(Scientific Procedures) Act 1986, UK. The mesenteric arcade was removed and 
placed in ice-cold MOPS buffer containing (mM): 145 NaCl, 4.7 KCl, 2.0 CaCl2, 1.17 
MgSO4·7H2O, 2.0 MOPS, 1.2 NaH2PO4·H2O, 5.0 glucose, 2.0 pyruvate, 0.02 EDTA, 
2.75 NaOH with pH adjusted to 7.40 ± 0.02 (at 37ºC). A third-order segment of 
mesenteric artery (external diameter between 250-350 µm at 70 mmHg) with no 
visible side branches was dissected free of adherent tissue. After the artery was 
mounted in either a pressure or wire myograph, reactivity was assessed by 
preconstriction with phenylephrine (PE, 0.5-3 µM) followed by endothelium-
dependent relaxation to acetylcholine (ACh, 0.1 and 1 µM). Only vessels that relaxed 
by more than 95% to 1 µM ACh were used further. 
 
Measurement of vascular responses 
Arteries were cannulated with two glass pipettes in a temperature-regulated chamber 
(10 mL, 120CP, Danish Myo Technology, Denmark) placed on the stage of an 
inverted microscope (IX71, Olympus, Japan) as previously described (Yuill et al., 
2011). The preparations were then warmed to 37°C, and pressure, driven by custom-
built gravity-fed inflow and outflow system, was gradually increased to 70 mmHg. 
Arteries were visualized using a 10x/0.25 Olympus objective and video camera (KP-
M1E/K-S10, Hitachi Kokusai Electric Inc., Japan) and vessel diameter changes A
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tracked using Vedi View software (v.1.2, Photonics Engineering). All experiments 
were performed in the presence of continuous luminal flow (5 µL/min; Bee Hive 
syringe pump system, Bioanalytical Systems, USA) that had no effect on tone. 
Arteries were pre-constricted with PE (or other agonist, as indicated) to 70-80% of the 
minimum arterial diameter, and cumulative concentration response curves to ACh 
were obtained following addition to the bath solution. To rapidly introduce agonists to 
the lumen of arteries without disconnecting perfusion lines, an infusion manifold 
connected to multiple syringe pumps was positioned to the inflow line of one 
cannulating pipette.  
 
Measurement of smooth muscle membrane potential 
Segments of mesenteric artery (2 mm) were mounted in a Mulvany-Halpern wire 
myograph (model 400A, Danish Myo Technology, Denmark) in Krebs solution 
containing (mM): 118 NaCl, 25 NaHCO3, 3.6 KCl, 1.2 MgSO4·7H2O, 1.2 KH2PO4, 
11 glucose, and gassed with 21 % O2, 5 % CO2, balance N2 at 37ºC. During 
experiments, the concentration of CaCl2 was either 1 mM or 2.5 mM, as stated. With 
1 mM [Ca2+]o, there was no significant difference in EC50 and EMax for 
hyperpolarization to ACh in arteries bathed in either MOPS buffered solutions or 
Krebs-buffered physiological solution (See Supplementary Figure 1A). The 
temperature was increased to 37ºC, and arteries normalized to a resting tension 
equivalent to that generated at 90% of the diameter of the vessel at 70 mmHg. The 
viability of the artery was assessed with PE and ACh, as described above.  
 
The smooth muscle membrane potential was measured using sharp glass 
microelectrodes backfilled with 2 M KCl (tip resistances circa 100 MΩ), as A
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previously described (Garland & McPherson, 1992; Garland et al., 2011b). Membrane 
potential was recorded through a pre-amplifier (Neurolog system, Digitimer Ltd., 
U.K.) linked to a MacLab data acquisition system (AD Instruments Model 4e, usually 
at 100 Hz). All drugs were added directly to the bath. 
 
Measurement of endothelial cell sheet membrane potential 
For patch clamp studies, endothelial cells were isolated from mesenteric arteries that 
had been cut open and placed in nominally Ca2+-free physiological saline solution 
(HEPES-PSS) containing (mM): 130 NaCl, 5 KCl, 1.2 MgCl2, 10 glucose, 10 HEPES 
(pH adjusted to 7.4 with NaOH) with the additional presence of 1 mg/ml papain, 
1mg/ml bovine serum albumin (BSA, fraction V) and 1 mg/ml dithiothreitol for 10 
min at room temperature and then for 30 min at 36º C. The arteries were then washed 
in Ca2+-free BSA-containing HEPES-PSS and gently triturated to release endothelial 
cells. Cell suspensions were stored on ice (the Ca2+ concentration was gradually 
increased to 0.5 mM) and used on the same day. All patch-clamp recordings were 
performed in HEPES-PSS containing 1 mM CaCl2, 100 µM L-NAME and 10 µM 
indomethacin. The recording pipette solution contained (mM): 140 KCl, 2 MgATP, 
0.1 Na2GTP, 0.5 MgCl2, 10 HEPES, 0.1 EGTA, pH adjusted to 7.2 with KOH.  
 
Membrane potential was recorded from endothelial cell sheets (containing between 3 
and >20 cells) using the current clamp mode of the whole-cell patch clamp technique 
at sampling rate 10 Hz (Axoclamp 200B amplifier; Axon Instruments, Union City, 
CA, USA). Pipette resistance, when filled with pipette solution, was 5-10 MΩ.  
 
 
Measurement of endothelial [Ca2+]i changes A
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In separate experiments, small mesenteric arteries were dissected, cannulated and 
reactivity assessed as described previously. Endothelial cells were then loaded with a 
combination of Ca2+ reporter dyes. Briefly, the intraluminal pressure was lowered to 4 
mmHg and the artery perfused with buffer containing 0.02% Pluronic F-127 and the 
cell-permeable Ca2+ dye Fura Red AM (40 µM, 25 min) followed 30 min later with 
Oregon Green 488 BAPTA-1 AM (OGB-1, 10 µM, 30 min), selectively to load 
endothelial cells (Kansui et al., 2008). After the dye was washed out of the chamber 
with MOPS buffer, the pressure was increased and the artery left for another 30 
minutes to allow de-esterification. Arteries were then exited at 488 nm and emitted 
light simultaneously collected at 505-525 nm (OGB-1) and 655-755 nm (Fura Red) 
with a 40x water immersion objective (UApo N340, Olympus, Japan) mounted on an 
Olympus FluoView1000 microscope (Olympus, Japan). Endothelial cells were 
visualised in a clip box of 476x156 pixels allowing a scan frequency of ~3 Hz. Cells 
(6-10 cells) were selected and fluorescence intensity was determined off-line using 
MetaMorph software (v.7.7.4, Molecular Devices, USA). Raw fluorescence values at 
each time point for each indicator dye were divided (to give a ratio FOGB-1/FFura Red), 
and normalized to a 10 s period before the addition of ACh (F/F0) to give values for 
Ratio F/F0. Each summary data value is the average of at least a 20 s period. 
Performing a ratio enabled more accurate comparisons of fluorescence changes to 
various concentrations of ACh before and after exposure to isoprenaline, each being 
paired. All agonists were added to the bath. 
 
Data analysis  
Data were analyzed using Microsoft Excel 2011 (Microsoft Corporation) and 
GraphPad Prism (v5.0, GraphPad Software, USA) software. Dilatation was expressed A
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as a percentage reversal of tone induced by PE (100% corresponding to the maximal 
diameter). Results are summarised as mean ± S.E.M. of n replicates, where n is the 
number of individual arteries, each obtained from a separate animal. Statistical 
analyses were performed using Student's unpaired t-test, one-way or two-way 
ANOVA analysis followed by Bonferroni post-test. A value of P < 0.05 was 
considered to be statistically significant.  
 
Drugs and solutions 
All drugs were obtained from Sigma (Poole, UK) with the exception of apamin 
(Latoxan, France), and forskolin (Biomol International). U46619, TRAM-34 (1-[(2-
chlorophenyl)diphenylmethyl]-1H-pyrazole) and forskolin were dissolved in dimethyl 
sulfoxide, while adrenaline and noradrenaline bitartrate salts were dissolved in 10-4 M 
ascorbic acid. All other stock solutions were prepared using purified (MilliQ) water. 
All stock solutions were prepared at 10-2 M, except for L-NAME (10-1 M), and 
subsequently diluted in MOPS buffer (pressurized arteries), Krebs buffer (wire 
myograph) or HEPES-PSS (patch clamp). Inhibitors were pre-incubated with the 
arterial tissue for at least 20 mins before agonist application. 
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Results 
Intraluminal perfusion of β-adrenoceptor agonists inhibits endothelium-dependent 
dilatation to ACh  
In pressurized small mesenteric arteries pre-contracted with PE, ACh (1 nM to 10 
µM) stimulated concentration-dependent dilatation (pEC50 = 7.1 ± 0.02, n = 5; Figure 
1A). When either adrenaline or NA (1 µM) were luminally perfused in PE pre-
contracted arteries, neither stimulated contraction, even in the presence of propranolol 
(1 µM, n = 4-9). However the luminal perfusion of β-adrenoceptor agonists reversibly 
inhibited ACh-mediated dilatation. Isoprenaline (1 µM), NA (1 µM) or adrenaline 
(0.5 µM) each right-shifted ACh concentration response curves (isoprenaline: from 
pEC50 = 7.2 ± 0.01 to pEC50 = 6.4 ± 0.03, n = 6, P<0.05, Figure 1B; NA: to pEC50 = 
6.4 ± 0.3, n = 6, P<0.05, Figure 1C; adrenaline: to pEC50 = 6.6 ± 0.02, n = 6, P<0.05, 
Figure 1D). Inhibition of dilatation to ACh was mimicked by activation of adenylyl 
cyclase by luminal perfusion of forskolin (0.5-1 µM; from pEC50 = 7.2 ± 0.02 to 
pEC50 = 6.5 ± 0.03, n = 5, P<0.05; Figure 1E). In contrast to the action of β-
adrenoceptor agonists, luminal perfusion of either MOPS buffer alone or the α1-
adrenoceptor agonist, PE (0.5 µM, n = 5), did not modify responses to ACh. 
 
The ability of isoprenaline to inhibit endothelium-dependent dilatation to ACh was 
blocked by pre-treatment of arteries with the PKA inhibitor KT 5720 that alone had 
no effect (1 µM; Figure 2A), but not by the KATP channel blocker glibenclamide (10 
µM, Figure 2B). Glibenclamide was used to prevent the hyperpolarization that is 
stimulated by isoprenaline through the opening of smooth muscle KATP channels in 
this artery, a change that could potentially interfere with EDH-mediated 
hyperpolarization to ACh by decreasing the driving force for K+ efflux.  A
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β-Adrenoceptor stimulation inhibits endothelium-dependent hyperpolarization to ACh
 
 
IKCa channels can be activated at resting membrane potentials in the mesenteric artery 
in Krebs buffered solution containing 1 mM, but not 2.5 mM, [Ca2+]o (Dora et al., 
2008). The resting membrane potential in 1 mM [Ca2+]o (-51.5 ± 0.7 mV, n = 8) was 
no different to cells in the same arteries in 2.5 mM [Ca2+]o Krebs (-52.4 ± 0.8 mV, n = 
6). However, in the presence of 50 nM apamin (to remove SKCa input) raising [Ca2+]o 
from 1 mM to 2.5 mM evoked a transient hyperpolarization (peak of -7.1 ± 1.8 mV at 
38 ± 10 s after addition, n = 5) which reversed completely over the next 20 min (to -
0.6 ± 1.3 mV by 9 ± 4 min, n = 5). This acute hyperpolarization as [Ca2+]o is raised 
above 1 mM has been shown previously, and ascribed to activation of IKCa channels 
through calcium-sensing receptors on the endothelium (see trace in Weston et al., 
2005). 
 
In 1 mM [Ca2+]o Krebs, ACh evoked concentration-dependent smooth muscle 
hyperpolarization (from a resting potential of -54.2 ± 1.8 mV, by a maximum of 20.9 
± 1.1 mV, pEC50 = 7.2 ± 0.11, n = 5). In the presence of 10 µM glibenclamide, to 
block β-adrenoceptor-stimulated hyperpolarization, isoprenaline (1 µM) significantly 
suppressed the smooth muscle hyperpolarization to ACh (decreased to a maximum of 
13.1 ± 1.3 mV, from a resting potential of -53.8 ± 0.9 mV, n = 5; Figure 3A top (i) 
and middle trace (ii) & 3B). The ACh-hyperpolarization that persisted in the presence 
of isoprenaline was mediated by SKCa, as it was blocked by 50 nM apamin (Figure 3A 
bottom trace (iii), summary data Figure 3B). Apamin alone depressed ACh-
hyperpolarization to a similar extent to isoprenaline (Figure 3B). Atenolol (1 µM, 
selective β1-adrenoceptor antagonist) prevented isoprenaline from blocking the ACh- A
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IKCa hyperpolarization (that persisted in the presence of apamin, Figure 3B, n = 6). 
Atenolol did not alter the concentration-dependent hyperpolarization to ACh in the 
presence of apamin (maximum of 13.5 ± 1.9 mV, n = 5).  
 
In freshly isolated endothelial cell sheets incubated with apamin, ACh (1 µM) applied 
for 30 s every 5 mins evoked reproducible and reversible hyperpolarization that was 
blocked in a time dependent manner with isoprenaline (1 µM, Figure 3C and 
summarized in Figure 3D). These data demonstrate the presence of functional β-
adrenoceptors in endothelial cells of mesenteric arteries, and confirm their role in 
suppressing the ability of ACh to activate endothelial cell IKCa channels.  
 
Endothelial IKCa channels underlie β-adrenoceptor inhibition of endothelium-
dependent hyperpolarization 
Noradrenaline suppressed ACh-hyperpolarization to a similar extent as isoprenaline. 
In 1 mM [Ca2+]o Krebs, ACh stimulated a maximum hyperpolarization of 20.5 ± 1.7 
mV (pEC50 = 7.0 ± 0.03, initial membrane potential -51.5 ± 0.7 mV, n = 8). In the 
presence of prazosin (1 µM, to block α1-adrenoceptors) and glibenclamide, NA (1 
µM) suppressed hyperpolarization (maximum now 11.1 ± 1.8 mV from a resting 
potential of -52.6 ± 0.7 mV, n = 5; Figure 4A & 4B). Apamin (50 nM) significantly 
reduced the remaining hyperpolarization (Figure 4B). TRAM-34 (1 µM) also 
supressed ACh-hyperpolarization, but in contrast to apamin it blocked the ability of 1 
µM NA to cause further inhibition of hyperpolarization (Figure 4C), consistent with 
an effect of NA against IKCa channels. The combination of apamin and TRAM-34 
abolished hyperpolarization to ACh (Figure 4C), but did not prevent hyperpolarization 
to the opener of KATP channels levcromakalim (5 µM, -22.3 ± 2.0 mV, n = 3). When A
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[Ca2+]o was increased to 2.5 mM, an inhibitory effect of NA against EDH-
hyperpolarization was not observed (maximum hyperpolarization to ACh of -21.2 ± 
1.8 mV was not reduced in the presence of NA, -19.3 ± 1.5 mV, n = 6 & 4, Figure 
4D). In 2.5 mM [Ca2+]o, ACh-mediated hyperpolarization is entirely due to SKCa 
channel activation (Crane et al., 2003; Dora et al., 2008). 
 
Endothelial IKCa channels underlie β-adrenoceptor inhibition of endothelium-
dependent dilatation to ACh 
As shown previously, inhibition of NO synthase right-shifted the concentration-
response curve to ACh without depressing the maximum response (100 µM L-
NAME, pEC50 from 7.2 ± 0.04 to 6.8 ± 0.1, n = 6, P<0.05). The residual dilatation is 
due to hyperpolarization (EDH-dilatation, Crane et al., 2003), and was reduced by 
apamin (50 nM; pEC50 = 6.2 ± 0.1, n = 6, P<0.05), then markedly suppressed by the 
subsequent addition of TRAM-34 (1 µM, n = 5, P<0.05; Figure 5A).  
 
EDH dilatation obtained in the presence of L-NAME was suppressed by luminal 
perfusion of NA (from pEC50 = 6.8 ± 0.02 to pEC50 = 6.2 ± 0.03, n = 4, P<0.05; 
Figure 5B). The addition of TRAM-34 now failed to depress dilatation further (pEC50 
= 6.2 ± 0.04, n = 4, P>0.05), and NA together with apamin (50 nM) was equally 
effective at blocking ACh dilatation as TRAM-34 and apamin. If SKCa (rather than 
IKCa) channels were blocked (with apamin), each catecholamine (n = 4, P<0.05) or 
forskolin (n = 5, P<0.05) inhibited EDH-dilatation to ACh in a manner similar to 
apamin and TRAM-34 (Figures 5B & C). These data are consistent with the sharp 
electrode data, and further support an effect of both β-adrenoceptor agonists and 
activators of PKA against IKCa channels. A
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β1-adrenoceptors mediate inhibition of EDH-dilatation  
The ability of β-adrenoceptor stimulation to suppress EDH-dilatation in the presence 
of apamin was blocked in the presence of either propranolol (1 µM, non-selective β-
adrenoceptor antagonist, n =4) or atenolol (1 µM, selective β1-adrenoceptor 
antagonist, n = 3). In each case, the subsequent addition of TRAM-34 abolished the 
persistent dilatation (n = 3-4, Figures 6A & 6B). In contrast, the β2-adrenoceptor 
antagonist ICI 18,551 (100 nM) did not prevent the NA-mediated inhibition of ACh 
responses in the presence of apamin (Figure 6C, n = 4, P<0.05). Together these data 
support an inhibitory action of catecholamines via β1-adrenoceptors. 
 
β1-adrenoceptors do not modify increases in endothelial [Ca2+]i to ACh 
Endothelial cells were imaged in pressurized arteries (Figure 7A). Concentration-
dependent increases in cytoplasmic [Ca2+]i were stimulated by ACh and detected 
ratiometrically (Figure 7B-D).  Prior exposure to 1 µM isoprenaline did not alter 
increases evoked by ACh (n = 3-4, P>0.05; Figure 7C (ii) and 7D).  
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Discussion  
We have shown that activation of vascular β-adrenoceptors can markedly reduce 
endothelium-dependent dilatation to ACh. This effect appears due to the activation of 
endothelial cell β1-adrenoceptors that couple via PKA to suppress hyperpolarization 
generated by endothelial cell IKCa channels. The observation that this inhibitory action 
was evoked by luminal perfusion of isoprenaline, and can be mimicked by either 
adrenaline or noradrenaline, suggests it is of physiological relevance in situations 
when circulating levels of catecholamines are raised.  
 
Through the generation of NO, hyperpolarization (EDH) and in some arteries 
prostanoids, the endothelium relaxes the adjacent smooth muscle cells resulting in 
vasodilatation.  In smaller resistance arteries, EDH is the predominant functional 
influence on the smooth muscle. EDH is activated by agonists, including ACh, that 
elevate endothelial cell [Ca2+]i opening both SKCa and IKCa channels localized within 
the endothelium (Dora, 2010; Garland et al., 2011a). These distinct KCa channels are 
differentially distributed within the endothelial cell membrane, and IKCa channels can 
be controlled independently of SKCa (Crane et al., 2003; Dora, 2010; Garland et al., 
2011a). The SKCa channels reside within caveolae and appear to be particularly 
concentrated around the large homocellular gap junctions between endothelial cells. 
In contrast, IKCa channels are restricted to thin projections of the endothelial cell 
directed toward the adjacent smooth muscle (Dora et al., 2008; Sandow et al., 2006). 
Interestingly, the IKCa channels appear to reside outside the caveolae, and are found in 
close association with Ca2+-sensing receptors, receptors that have been shown to 
modulate the activity of these K+ channels (Absi et al., 2007; Weston et al., 2005). A
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Endothelial cell projections therefore represent a complex signalling microdomain 
that seems to have a central role in the physiological control of artery diameter.  
 
Hyperpolarization generated by IKCa-channels can be regulated by the cAMP 
signalling pathway, as it is suppressed by forskolin (Dora et al., 2008). Although there 
is very little data available regarding the regulation of IKCa channels by PKA, and 
only the one report in arteries (by Dora et al., 2008), an inhibitory influence on 
channel activity mediated through cAMP signalling has been reported in other cell 
types. For example, PKA activation inhibited IKCa currents in ganglia within guinea-
pig duodenum (Vogalis et al., 2003) and through channels expressed in Xenopus 
oocytes (Neylon et al., 2004). Furthermore, in mouse jejunum, forskolin suppressed 
the Cl- secretion evoked by the IKCa channel opener DCEBIO (Hamilton & Kiessling, 
2006). Therefore, our data now put the responses to forskolin into a more 
physiological context, by suggesting PKA-mediated inhibition of IKCa as a 
mechanism for suppression of EDH-dilatation during vascular β-adrenoceptor 
stimulation. It is likely the effect may be explained by PKA phosphorylation of IKCa 
channels, analogous to the effect of PKA in other cell types. PKA phosphorylates sites 
located within the calmodulin-binding domain of the IKCa channel in Xenopus oocytes 
(Neylon et al., 2004), and a similar mechanism has been suggested to explain the 
suppression of IKCa current within enteric neurons (Neylon et al., 2006; Vogalis et al., 
2003). Alternatively, a pathway independent of the phosphorylation of IKCa channels 
could occur as a result of reduced increases in cytoplasmic [Ca2+]i to ACh. While 
isoprenaline stimulation associated with increases in cAMP in cultured bovine aortic 
endothelial cells had no effect on [Ca2+]i itself, it did reduce endothelial cell Ca2+ 
responses to ATP (Luckhoff et al., 1990). To address this possibility in the present A
cc
ep
te
d 
A
rti
cl
e
© 2013 The Authors 
British Journal of Pharmacology © 2013 The British Pharmacological Society 
19 
study, we showed that ACh-evoked increases in endothelial cell Ca2+ were not 
affected by isoprenaline in intact arteries. However, we cannot rule out the possibility 
that very discrete changes in [Ca2+]i do occur but are restricted to the immediate 
vicinity of the IKCa channels. We would not be able to resolve such changes with our 
imaging approach. Finally, by using glibenclamide we ruled out the possibility that 
KATP channel opening might interfere with EDH-mediated hyperpolarization to ACh 
simply by decreasing the driving force for K+ efflux. KATP channels are known to 
underlie the hyperpolarization to isoprenaline (and other catecholamines) in rat 
mesenteric arteries (Fujii et al., 1999; Takano et al., 2004; White & Hiley, 2000b).  
 
The observation that β1-adrenoceptors appear to account for the inhibition of IKCa 
channels by catecholamines ties these receptors to endothelial cells, as IKCa channels 
are not expressed in the smooth muscle cells of this artery (Walker et al., 2001). This 
point is supported directly by the observation that atenolol blocked isoprenaline's 
ability to inhibit ACh-evoked (IKCa) hyperpolarization, and by our patch clamp data 
from isolated endothelial cells where isoprenaline was fully able to block IKCa 
channel current. Previous evidence to suggest that β-adrenoceptors are located on 
endothelial cells in the mesenteric artery comes from the specific binding of a 
fluorescent β-adrenoceptor ligand, BIODIPY TMR-CGP 12177, within the intima of 
these arteries (as well as in both the media and adventitia) (Briones et al., 2005; Daly 
et al., 2010). Previous functional studies have also been interpreted to indicate β1-
adrenoceptors are present on mesenteric artery endothelial cells, as dobutamine-
mediated relaxation (against high KCl pre-contraction) was attenuated either by block 
of NO synthase or removal of the endothelium, whereas relaxation to salbutamol was 
not sensitive to L-NAME (Graves & Poston, 1993). A
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β1 rather than β2-adrenoceptors predominate in the mesenteric artery (Briones et al., 
2005; Garland et al., 2011b). This is in itself interesting, because although both 
receptor subtypes associate with caveolae, the β1-adrenoceptor is more widely 
distributed through the cell membrane and known to associate with extra-caveolar cell 
fractions, at least in cardiac myocytes (Rybin et al., 2000). β1-adrenoceptors may 
therefore reside in membrane regions that also contain IKCa channels. If β1-
adrenoceptors do align in close proximity to the IKCa channels in endothelial cell 
projections, they will be ideally placed to influence the activity of these strategically 
positioned K-channels.   
 
The fact that β1-adrenoceptor stimulation can inhibit endothelial cell IKCa channels, 
and as a result depress EDH-mediated vasodilatation, seems strange as β1-
adrenoceptors also evoke potent smooth muscle relaxation that is associated with and 
in part reflects hyperpolarization (Garland et al., 2011c). However, the 
hyperpolarization caused by β1-adrenoceptors is entirely due to KATP channel 
activation, and at least in the mesenteric artery these channels are only present on the 
smooth muscle, not on endothelial cells (Takano et al., 2004; White & Hiley, 2000a).  
One possibility, is that in vivo endothelial IKCa channels are influenced primarily by 
circulating β-adrenoceptor agonists, so at least in mesenteric vessels the depression of 
endothelial function enhances vasoconstriction. 
 
As EDH is activated by any agent that increases endothelial cell [Ca2+]i, β1-
adrenoceptor stimulation would be predicted to depress vasodilatation to a range of 
physiologically active autacoids. This may then explain the known ability of raised A
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plasma catecholamine concentrations to impair endothelial function in humans 
(Higashi et al., 2002; Kuklinska et al., 2010). In the coronary microvasculature,   
dysfunction associated with elevated levels of catecholmaines is thought to play an 
important part in the development of tako-tsubo syndrome, and depressed endothelial 
cell activity has also been associated with raised sympathetic nerve activity and 
suggested to involve β-adrenoceptors (De Caterina et al., 2011; Pettersson et al., 
1990). So reducing the endogenous stimulation of vascular β-adrenoceptors could 
explain in part the beneficial effects of β-blockers (Broeders et al., 2000; Gupta & 
Wright, 2008; Priviero et al., 2007; Reiter, 2004; Tzemos et al., 2001; Wenzel et al., 
2009). 
 
In summary, luminal perfusion of β-adrenoceptor agonists causes a significant 
suppression in endothelium-dependent vasodilation. This action is mediated through 
β1-adrenoceptors, most probably located on the endothelium, and reflects inhibition of 
endothelial cell IKCa channels that serves to depresse endothelial cell 
hyperpolarization.  
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Figure Legends 
 
Figure 1  Luminal perfusion of adrenoceptor agonists inhibit endothelium-
dependent dilatation to ACh in pressurized mesenteric arteries.  
Original traces illustrate dilatation to increasing ACh concentrations (1 nM – 10 µM) 
in an artery pre-constricted with PE. Luminal perfusion of 1 µM NA (black line: 
control buffer only; green line: luminal NA present) inhibits dilatation (A). 
Summarized data showing luminal perfusion of 1 µM isoprenaline inhibits dilatation 
to ACh and is restored on washout of isoprenaline (n = 4, B). Similar inhibition 
follows luminal perfusion of the adrenergic agonists 1 µM NA (n = 6, C) or 0.5 µM 
adrenaline (n = 6, D), or activation of adenylyl cyclase with 0.5 µM luminal forskolin 
(n = 5, E). Results shown are the mean ± s.e.mean; *P<0.05 vs. control, paired data. 
 
Figure 2  KT 5720 but not glibenclamide prevents β-adrenoceptor inhibition of 
endothelium-dependent dilatation to ACh.  
The PKA inhibitor KT 5720 (1 µM, A) did not modify endothelium-dependent 
vasodilatation to ACh (n = 5) but prevented the isoprenaline-mediated inhibition of 
dilatation to ACh (n = 4, A). The ability of isoprenaline to inhibit dilatation to ACh 
was not altered in the presence of glibenclamide (10 µM, n = 4; B). Data are the mean 
± s.e.mean; *P<0.05 vs. control, paired data.  
 
Figure 3  Isoprenaline inhibits IKCa channel hyperpolarization evoked by ACh  
Original trace of smooth muscle cell membrane potential recording showing ACh-
evoked, concentration-dependent hyperpolarization (Ai) inhibited in the presence of  
1 µM isoprenaline (Aii) and blocked in the additional presence of 50 nM apamin 
(Aiii). (B) Summary of intracellular recordings showing similar depression of ACh A
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hyperpolarization with 1 µM isoprenaline or 50 nM apamin present; *P<0.05 vs. 
control, paired data, n = 5. In combination, isoprenaline and apamin abolished 
hyperpolarization to ACh; #P<0.05 vs. isoprenaline, †P<0.05 vs. apamin, paired data, 
n = 5, and this block was prevented by the presence of 1 µM atenolol (n = 6). Note 
that TRAM-34 blocks the same component as isoprenaline (see Figure 4C). (C) 
Original traces of endothelial cell membrane potential recorded in endothelial cell 
sheets. Sequential exposure to 1 µM ACh (added at arrowhead, superimposed traces 
1-5, each 30 s) stimulated endothelial cell hyperpolarization, which was blocked in a 
time-dependent manner by prior incubation with 1 µM isoprenaline (traces 4 & 5). 
(D) Summary of patch clamp data in endothelial cell sheets showing 
hyperpolarization to ACh (1 µM) in the presence of apamin (100 nM) was blocked in 
the presence of 1 µM isoprenaline; *P<0.05, n = 4. Data are expressed as the area 
under the curve (AUC) and corrected for the basal membrane potential. Summary data 
are the mean ± s.e.mean; 100 µM L-NAME present in all experiments, Krebs and 
HEPES buffers contained 1 mM Ca2+ to prevent inhibition of IKCa channels by [Ca2+]o 
(Dora et al., 2008; Weston et al., 2005). 
 
Figure 4  TRAM-34 but not apamin blocks β-adrenoceptor mediated inhibition of 
hyperpolarization evoked by ACh. 
(A) Original trace of smooth muscle membrane potential showing hyperpolarization 
to cumulative addition of ACh (1 nM – 3 µM) has been suppressed during incubation 
with NA (1 µM) (see control trace in Figure 3Ai). (B) Summarized data showing 
ACh-mediated hyperpolarization is partially suppressed in the presence of 1 µM NA 
(n = 7, *P<0.05) and further by the additional presence of apamin (50 nM, n = 6, 
†P<0.05 vs. apamin, see Figure 4C, and #P<0.05 vs. NA). (C) TRAM-34 (1 µM) A
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depressed ACh-mediated hyperpolarization, 1 µM NA had no further effect, *P<0.05 
vs. control, n = 6 in each case; whereas TRAM-34 together with apamin fully blocked 
hyperpolarization to ACh, §P<0.05 vs. TRAM-34, n = 3. (D) 1 µM NA did not modify 
endothelium-dependent hyperpolarization to ACh in mesenteric arteries bathed in 
Krebs buffer containing 2.5 mM Ca2+ (n = 4-6). All data shown are the paired mean ± 
s.e.mean; 100 µM L-NAME, 1 µM prazosin and 10 µM glibenclamide were present in 
all experiments when NA was present. Krebs buffer contained 1 mM Ca2+ to prevent 
inhibition of IKCa channels by [Ca2+]o, unless otherwise stated.  
 
Figure 5 TRAM-34 but not apamin prevents the inhibition of endothelium-
dependent dilatation to ACh by β-agonists in pressurized small mesenteric arteries.  
(A) Inhibition of NO synthesis with L-NAME (100 µM), and EDH with apamin (50 
nM, to block SKCa channels) together with TRAM-34 (1 µM, to block IKCa channels) 
suppressed dilatation to ACh in arteries pre-contracted with PE (n = 5). (B) In the 
presence of L-NAME, luminal perfusion of 1 µM NA alone suppressed dilatation to 
ACh and prevented further inhibition with TRAM-34 (n = 4, P>0.05), whereas 
apamin blocked a further component, similar to that observed with apamin and 
TRAM-34 (A). (C) Similarly, in the presence of apamin, luminal perfusion of other β-
adrenoceptor agonists  (1 µM isoprenaline or 0.5 µM adrenaline) or 0.5 µM forskolin, 
blocked the same TRAM-34-sensitive IKCa channel component of ACh responses. All 
data are paired and represent the mean ± s.e.mean, n = 4-7; *P<0.05 vs. control; 
#P<0.05 vs. β-adrenoceptor agonist alone; †P<0.001 vs. KCa channel blocker alone.  
 
Figure 6  β1-adrenoceptors underlie inhibition of endothelium-dependent (EDH)-
dilatation to ACh in pressurized small mesenteric arteries. A
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(A) In the presence of propranolol (1 µM), ACh-mediated dilatation associated with 
IKCa channel activity (obtained in the presence of 100 µM L-NAME and 50 nM 
apamin) was not inhibited by luminal NA (1 µM), confirming a role for β-
adrenoceptors in the actions of NA (see Figure 5B). IKCa channels alone underpinned 
the dilatation, as the subsequent addition of TRAM-34 (1 µM) abolished ACh-
mediated dilatation (n = 4). (B) A similar profile of block was observed using the 
selective β1-adrenoceptor antagonist atenolol (1 µM, n = 6); while the β2-adrenoceptor 
antagonist ICI 118,551 (100 nM) did not prevent the inhibitory action of NA on ACh-
mediated dilatation (n = 4; C). Data are mean ± s.e.mean and paired; †P<0.05 vs. L-N 
and apamin in Figure 5A; §P<0.05 vs. ICI 118,551 + L-N + apamin + NA. 
 
Figure 7  Isoprenaline did not alter ACh-evoked increases in endothelial cell 
[Ca2+]i in pressurized mesenteric arteries. 
(A) Confocal fluorescent image of endothelial cells in a pressurized artery loaded with 
the Ca2+ indicators Oregon Green 488 BAPTA-1 (OGB-1) and Fura Red. (B) Original 
traces showing the time course of fluorescence intensity changes for each indicator 
dye (FFura Red and FOGB-1, arbitrary units), following application of 0.3 µM ACh to the 
bath at the point indicated by arrows. Note that FFura Red decreases upon binding Ca2+. 
(C) Top panel: raw values in B were divided to give a ratio (FOGB-1/FFura Red), and 
normalized to a 10 s period before the addition of ACh (F/F0) to give values for Ratio 
F/F0. Bottom panel: repeated in the presence of 1 µM isoprenaline, paired data.  (D) 
Paired values for each experiment and concentration of ACh show no trend for 
isoprenaline to alter the average increase in Ratio F/F0. Summary data for each 
concentration of ACh (n = 3-4) show no deviation from equality (dashed line); data 
are the mean ± s.e.mean; P>0.05 vs. control. A
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Supplementary Figure 1 Different buffer compositions do not affect 
hyperpolarization to ACh 
Summary data showing smooth muscle membrane potential increases in response to 
endothelial cell stimulation with ACh in mesenteric arteries bathed either in Krebs (1 
mM Ca2+, n = 5; 2.5 mM Ca2+, n = 6) or MOPS buffer (1 mM Ca2+, n = 3-4; 2 mM 
Ca2+, n = 3) in the presence of 100 µM L-NAME. Concentration-dependent 
hyperpolarization to ACh was the same in each case. Data are the mean ± s.e.mean. 
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